Product
PF-07104091 + Palbociclib + Letrozole
1 clinical trial
3 indications
Indication
Small Cell Lung CancerIndication
Ovarian CancerIndication
Breast CancerClinical trial
PHASE 1/2A DOSE ESCALATION, FINDING AND EXPANSION STUDY EVALUATING SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND ANTI TUMOR ACTIVITY OF PF-07104091 AS A SINGLE AGENT AND IN COMBINATION THERAPYStatus: Recruiting, Estimated PCD: 2025-01-07